Please login to the form below

Not currently logged in
Email:
Password:

Stewart Sharpe appointed VP commercial operations at Circassia

Will lead launch plans for biopharma’s first product

UK-based biopharma Circassia has appointed pharma veteran Stewart Sharpe as its first VP of commercial operations.

He will lead Circassia's commercialisation for its lead allergy treatment ToleroMune, which is due to begin phase III testing by the end of 2012.

“We believe our ToleroMune technology has the potential to revolutionise allergy treatment,” said Steve Harris, Circassia's CEO. “As we move our lead programme into the final phase of development it is the ideal time to ramp up the extensive commercial preparations required for the successful international launch of our first product.

“Stewart brings to Circassia the senior-level experience and track record of achievement needed to help us achieve this ambitious goal.”

Sharpe joins Circassia from Astellas Pharma's OSI / Prosidion subsidiary, where he was head of commercial and business development.

Previously, he held senior leadership roles at Takeda, Johnson & Johnson, Novartis, Roche and Glaxo Wellcome.

His prior commercial efforts include leading the global launch of allergy treatment Xolair (omalizumab) for Novartis.

In addition, Sharpe is a member of the board of the Oxford Biosciences Network, a member of the UK Biotechnology Industry Association (BIA) and a member of the Chartered Institute of Marketing (CIM).

21st September 2012

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashley Communications

Ashley Communications is a unique medical communications consultancy providing outstandingdirector-only service tailored to individual client needs. The company philosophy is...

Latest intelligence

babylon virtual health service
VIDEO: Switching to a virtual health service
Ali Parsa, CEO and founder of babylon, discusses the benefits of conducting healthcare consultations via a smartphone...
Online Physician Communities
Is the pharma industry bad?
Surveys of doctors and the public suggest not...
Salary survey now open - how will you measure up?
Take part for a chance to win a Kindle Fire HD tablet...